These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 26545583)
21. miR-101 suppresses vascular endothelial growth factor C that inhibits migration and invasion and enhances cisplatin chemosensitivity of bladder cancer cells. Lei Y; Li B; Tong S; Qi L; Hu X; Cui Y; Li Z; He W; Zu X; Wang Z; Chen M PLoS One; 2015; 10(2):e0117809. PubMed ID: 25658842 [TBL] [Abstract][Full Text] [Related]
22. MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells. Liu S; Song L; Zeng S; Zhang L Tumour Biol; 2016 Jan; 37(1):633-40. PubMed ID: 26242259 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-106b-25 cluster targets β-TRCP2, increases the expression of Snail and enhances cell migration and invasion in H1299 (non small cell lung cancer) cells. Savita U; Karunagaran D Biochem Biophys Res Commun; 2013 May; 434(4):841-7. PubMed ID: 23611780 [TBL] [Abstract][Full Text] [Related]
24. miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer. Cai C; Chen QB; Han ZD; Zhang YQ; He HC; Chen JH; Chen YR; Yang SB; Wu YD; Zeng YR; Qin GQ; Liang YX; Dai QS; Jiang FN; Wu SL; Zeng GH; Zhong WD; Wu CL Clin Cancer Res; 2015 Nov; 21(21):4922-34. PubMed ID: 26080838 [TBL] [Abstract][Full Text] [Related]
25. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma. Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255 [TBL] [Abstract][Full Text] [Related]
26. microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements. Schwickert A; Weghake E; Brüggemann K; Engbers A; Brinkmann BF; Kemper B; Seggewiß J; Stock C; Ebnet K; Kiesel L; Riethmüller C; Götte M PLoS One; 2015; 10(12):e0143993. PubMed ID: 26657485 [TBL] [Abstract][Full Text] [Related]
27. miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma. Lu GJ; Dong YQ; Zhang QM; Di WY; Jiao LY; Gao QZ; Zhang CG Int J Clin Exp Pathol; 2015; 8(5):5224-9. PubMed ID: 26191221 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-1 and microRNA-499 downregulate the expression of the ets1 proto-oncogene in HepG2 cells. Wei W; Hu Z; Fu H; Tie Y; Zhang H; Wu Y; Zheng X Oncol Rep; 2012 Aug; 28(2):701-6. PubMed ID: 22664953 [TBL] [Abstract][Full Text] [Related]
29. mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer. Ludwig S; Sharma P; Wise P; Sposto R; Hollingshead D; Lamb J; Lang S; Fabbri M; Whiteside TL Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202950 [TBL] [Abstract][Full Text] [Related]
30. A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck. Liu Z; Wei S; Ma H; Zhao M; Myers JN; Weber RS; Sturgis EM; Wei Q Carcinogenesis; 2011 Nov; 32(11):1668-74. PubMed ID: 21934093 [TBL] [Abstract][Full Text] [Related]
31. MiR-374b-5p suppresses RECK expression and promotes gastric cancer cell invasion and metastasis. Xie J; Tan ZH; Tang X; Mo MS; Liu YP; Gan RL; Li Y; Zhang L; Li GQ World J Gastroenterol; 2014 Dec; 20(46):17439-47. PubMed ID: 25516656 [TBL] [Abstract][Full Text] [Related]
32. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor. Wang Z; Xue Y; Wang P; Zhu J; Ma J Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance. Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631 [TBL] [Abstract][Full Text] [Related]
34. Molecular pathogenesis of esophageal squamous cell carcinoma: Identification of the antitumor effects of miR‑145‑3p on gene regulation. Shimonosono M; Idichi T; Seki N; Yamada Y; Arai T; Arigami T; Sasaki K; Omoto I; Uchikado Y; Kita Y; Kurahara H; Maemura K; Natsugoe S Int J Oncol; 2019 Feb; 54(2):673-688. PubMed ID: 30535463 [TBL] [Abstract][Full Text] [Related]
35. MicroRNA-381 represses ID1 and is deregulated in lung adenocarcinoma. Rothschild SI; Tschan MP; Jaggi R; Fey MF; Gugger M; Gautschi O J Thorac Oncol; 2012 Jul; 7(7):1069-77. PubMed ID: 22592211 [TBL] [Abstract][Full Text] [Related]
36. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells. Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182 [TBL] [Abstract][Full Text] [Related]
37. MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Zheng B; Liang L; Wang C; Huang S; Cao X; Zha R; Liu L; Jia D; Tian Q; Wu J; Ye Y; Wang Q; Long Z; Zhou Y; Du C; He X; Shi Y Clin Cancer Res; 2011 Dec; 17(24):7574-83. PubMed ID: 21994419 [TBL] [Abstract][Full Text] [Related]
38. miR-133a functions as a tumor suppressor and directly targets FSCN1 in pancreatic cancer. Qin Y; Dang X; Li W; Ma Q Oncol Res; 2013; 21(6):353-63. PubMed ID: 25198665 [TBL] [Abstract][Full Text] [Related]
39. Restoration of miR-145 expression suppresses cell proliferation, migration and invasion in prostate cancer by targeting FSCN1. Fuse M; Nohata N; Kojima S; Sakamoto S; Chiyomaru T; Kawakami K; Enokida H; Nakagawa M; Naya Y; Ichikawa T; Seki N Int J Oncol; 2011 Apr; 38(4):1093-101. PubMed ID: 21258769 [TBL] [Abstract][Full Text] [Related]
40. Glutathione S-transferase P1 (GSTP1) suppresses cell apoptosis and its regulation by miR-133α in head and neck squamous cell carcinoma (HNSCC). Mutallip M; Nohata N; Hanazawa T; Kikkawa N; Horiguchi S; Fujimura L; Kawakami K; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N Int J Mol Med; 2011 Mar; 27(3):345-52. PubMed ID: 21181092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]